A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)

NCT01533532 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: KLH-2109
DRUG: KLH-2109
DRUG: KLH-2109
DRUG: placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.